- Home
- DERM vs LENZ Comparison
DERM vs LENZ Comparison
Compare DERM & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DERM | LENZ |
|---|---|---|
| Founded | 2014 | 2019 |
| Country | United States | United States |
| Employees | N/A | 152 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.9M | 185.0M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DERM | LENZ |
|---|---|---|
| Price | $6.68 | $6.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $12.67 | ★ $44.00 |
| AVG Volume (30 Days) | 356.1K | ★ 818.9K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $61,858,000.00 | $19,088,000.00 |
| Revenue This Year | $39.72 | $50.42 |
| Revenue Next Year | $63.24 | $197.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $5.23 |
| 52 Week High | $9.56 | $50.19 |
Technical Indicators
Market Signals| Indicator | DERM | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 53.44 | 45.27 |
| Support Level | $5.80 | $5.23 |
| Resistance Level | $8.23 | $10.42 |
| Average True Range (ATR) | 0.47 | 0.47 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 56.00 | 58.18 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.